Category: Patent Litigation
-
HMD faces new UPC complaints brought by Orange and Navigate (the latter over a Dolby patent)
Context: HMD’s most well-known standard-essential patent (SEP) dispute at the moment is with VoiceAge EVS (May 5, 2025 ip fray article). HMD also has yet to settle a licensing dispute with Huawei. And two months ago we reported on an Indian court hearing where it turned out that HMD initially offered, for the purposes of…
-
Pendulum swings back in favor of Fintiv in payment-system patent infringement dispute with Apple
The United States Court of Appeals for the Federal Circuit has reversed a Western District of Texas grant of summary judgment in a dispute between Fintiv and Apple, reviving Fintiv’s infringement claims and remanding them for trial.
-
Illumina sues Element Biosciences in Delaware over gene sequencing patents
While this is Illumina’s first official suit against Element Biosciences, the latter has already faced challenges over its gene sequencing technology based on prior art from Illumina’s assets.
-
UPC Dusseldorf issues first decision on second medical use, hands win to Amgen in cholesterol patent dispute against Sanofi
The Dusseldorf Local Division has clarified how the UPC deals with second medical use in patent infringement proceedings, including considering the extent or significance of the allegedly infringing use, and whether an entity is “positively” or “negatively” influencing a market by encouraging infringement, or preventing a product from being used for patented use.
-
Nintendo’s Japanese patent lawsuit against Pocketpair produces only losers, annoys consumers: game rules are wrong subject matter
Context: In January 2024, a small Japanese game maker named Pocketpair released Palworld, a game that literally became an overnight success of enormous proportions. It was described by some as “Pokémon with guns,” and Pokémon is Nintendo’s (and a joint venture name The Pokémon Company’s) crown jewel, besides Super Mario. That same month, the IP…
-
New UPC Dusseldorf injunction clarifies irrelevance of licensing talks to proportionality, stresses need to argue obviousness early
In a case involving circulation pumps for heating systems and other use cases, the UPC’s Dusseldorf LD has provided some clarifications of relevance to many other cases.
-
ITC updates: Infineon withdraws second of four patents against Innoscience, Oura bags smart ring patent victory
The United States International Trade Commission has issued a favorable initial determination for Oura in its smart ring case against rivals Ultrahuman and RingConn, while, in the gallium nitride wars, Infineon has withdrawn a second out of four patents asserted against its competitor Innoscience.
-
UPC’s Court of Appeal reverses denial of 17-country preliminary injunction in medical device case: Insulet prevails over EOFlow
The UPC’s Court of Appeal has previously upheld and overturned some preliminary injunctions, but like in any other jurisdiction it is difficult to get a denial of a PI reversed on appeal.
-
Apple owes more than $700M in standard-essential patent royalties and interest to licensing firm Optis: England & Wales Court of Appeal
Context: A couple of months ago, the England & Wales Court of Appeal (EWCA) heard Optis’s appeal against Apple (February 25, 2025 ip fray article). In 2023, Mr Justice Marcus Smith — who primarily serves as the President of the UK Competition Appeal Tribunal, but in this case presided over a standard-essential patent (SEP) litigation…